Skip to main content

Table 6 Standardized Incidence Ratios for 10 leading causes of cancer by year in trial.

From: Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials

Year of Study Year 1 Year 2 Year 3 Year 4 Year 5 Overall
Women years 198967 158235 107587 50362 8296 523447
Cancers Overall (excl. C56, C57.0, C44) 84.6% 90.8% 88.5% 91.7% 91.4% 88.1%
Lung Cancer 45.0% 61.5% 65.9% 64.1% 27.1% 56.2%
Breast Cancer 100.0% 106.1% 90.5% 99.9% 95.3% 99.8%
Colorectal Cancer 87.2% 96.7% 84.5% 98.4% 112.0% 91.1%
Pancreatic Cancer 57.4% 65.4% 88.4% 83.5% 0.0% 68.1%
Oesophagus Cancer 73.8% 61.6% 99.8% 37.1% 68.8% 71.6%
Stomach Cancer 78.5% 102.6% 72.2% 70.2% 152.7% 85.0%
N-H Lymphoma 91.5% 92.7% 137.8% 102.7% 131.1% 103.6%
Leukaemia 44.6% 75.5% 101.0% 138.1% 140.0% 77.7%
Uterus Cancer 96.3% 92.7% 94.1% 58.7% 109.2% 91.1%
Bladder Cancer 59.0% 90.9% 103.2% 82.6% 0.0% 79.5%
  1. Ovarian (C56)/tubal cancer (C57.0) and other malignant neoplasm of skin (C44) have been excluded. Average time in trial at censoring (1st June 2006) = 2.58 yrs/woman. Italicised values have 95% confidence intervals not containing 100.